MOA Study of Ze 339 in Seasonal Allergic Rhinitis

Summary

Randomised, double-blind and prospective clinical study to examine the mechanism of action of the Petasites hybridus leaf extract IG-RD-001 (Ze-339, petasol butenoate complex) compared to desloratadine and placebo in patients with seasonal allergic rhinitis of all degrees of severity (provoked by grasses). The treatment arm with desloratadine is an established standard treatment and is intended to ensure the comparative methodology of the study.

Timeline

Start

2008-01

Primary completion

2008-04

Completion

2008-12

Drugs

Indications